Cargando…

Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas

Recently, we have developed novel highly promising gene expression (GE) classifiers discriminating localized nodal (LFL) from systemic follicular lymphoma (SFL) with prognostic impact. However, few data are available in LFL especially concerning hotspot genetic alterations that are associated with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horn, Heike, Jurinovic, Vindi, Leich, Ellen, Kalmbach, Sabrina, Bausinger, Julia, Staiger, Annette M., Kurz, Katrin S., Möller, Peter, Bernd, Heinz-Wolfram, Feller, Alfred C., Koch, Karoline, Klapper, Wolfram, Stein, Harald, Hansmann, Martin-Leo, Hartmann, Sylvia, Scheubeck, Gabriel, Dreyling, Martin, Hiddemann, Wolfgang, Herfarth, Klaus, Engelhard, Marianne, Rosenwald, Andreas, Hoster, Eva, Ott, German
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371558/ https://www.ncbi.nlm.nih.gov/pubmed/35974958 http://dx.doi.org/10.1097/HS9.0000000000000767

Ejemplares similares

Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms
por: Kalmbach, Sabrina, et al.
Publicado: (2023)

Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression)
por: Scheubeck, Gabriel, et al.
Publicado: (2023)

Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial
por: König, Laila, et al.
Publicado: (2019)

Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma: Results of the MIR Study
por: Herfarth, Klaus, et al.
Publicado: (2018)

Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2
por: Horn, Heike, et al.
Publicado: (2018)

The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis
por: Fischer, Luca, et al.
Publicado: (2023)

Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group
por: Hirt, Carsten, et al.
Publicado: (2021)

The impact of SOCS1 mutations in diffuse large B‐cell lymphoma
por: Mellert, Kevin, et al.
Publicado: (2019)

Ki-67 as a prognostic marker in mantle cell lymphoma—consensus guidelines of the pathology panel of the European MCL Network
por: Klapper, Wolfram, et al.
Publicado: (2009)

Numerical and Structural Genomic Aberrations Are Reliably Detectable in Tissue Microarrays of Formalin-Fixed Paraffin-Embedded Tumor Samples by Fluorescence In-Situ Hybridization
por: Horn, Heike, et al.
Publicado: (2014)

Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Biological Data
por: Kurz, Katrin S., et al.
Publicado: (2023)

Long-term follow-up of cytogenetically normal CEBPA-mutated AML
por: Pastore, Friederike, et al.
Publicado: (2014)

Simultaneous Occurrence of Rosai–Dorfman Disease and Nodal Marginal Zone Lymphoma in a Patient with Sjögren's Syndrome
por: Gorodetskiy, Vadim R., et al.
Publicado: (2018)

Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome
por: Richter, Julia, et al.
Publicado: (2019)

Improved outcomes in metastatic germ cell cancer: results from a large cohort study
por: Hentrich, Marcus, et al.
Publicado: (2020)

A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia
por: Herold, Tobias, et al.
Publicado: (2018)

Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Concepts
por: Kurz, Katrin S., et al.
Publicado: (2023)

Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma
por: Villa, Diego, et al.
Publicado: (2022)

Priority-Lasso: a simple hierarchical approach to the prediction of clinical outcome using multi-omics data
por: Klau, Simon, et al.
Publicado: (2018)

Large-scale benchmark study of survival prediction methods using multi-omics data
por: Herrmann, Moritz, et al.
Publicado: (2020)

Molecular profiling of EBV associated diffuse large B-cell lymphoma
por: Frontzek, Fabian, et al.
Publicado: (2023)

Evolutionary clonal trajectories in nodular lymphocyte-predominant Hodgkin lymphoma with high risk of transformation
por: Paschold, Lisa, et al.
Publicado: (2021)

Follicular lymphoma grade 3B and diffuse large B-cell lymphoma present a histopathological and molecular continuum lacking features of progression/ transformation
por: Koch, Karoline, et al.
Publicado: (2022)

Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma
por: Stöcklein, Heike, et al.
Publicado: (2008)

Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling
por: Herbst, Andreas, et al.
Publicado: (2014)

Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium
por: Stevens, Wendy B.C., et al.
Publicado: (2017)

First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial
por: Braulke, Friederike, et al.
Publicado: (2022)

Establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application
por: Lerner, Cornelia, et al.
Publicado: (2014)

Detection of EBV in reactive and neoplastic lymphoproliferations in adults—when and how?
por: Stuhlmann-Laeisz, Christiane, et al.
Publicado: (2014)

Single Nucleotide Polymorphism Array Profiling of Adrenocortical Tumors - Evidence for an Adenoma Carcinoma Sequence?
por: Ronchi, Cristina L., et al.
Publicado: (2013)

Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas
por: Schümann, Franziska Lea, et al.
Publicado: (2021)

Cytogenetic determinants of male fertility
por: Martin, R.H.
Publicado: (2008)

Primary Diffuse Large B-Cell Lymphoma of the Liver in a Patient with Sjogren Syndrome
por: Gorodetskiy, Vadim, et al.
Publicado: (2016)

Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage
por: Leich, Ellen, et al.
Publicado: (2021)

An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence
por: Holler, Maximilian, et al.
Publicado: (2022)

Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
por: Herold, Tobias, et al.
Publicado: (2020)

“Classical cytogenetics” is not equal to “banding cytogenetics”
por: Liehr, Thomas
Publicado: (2017)

Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration
por: Tobin, Joshua W.D., et al.
Publicado: (2019)

Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma
por: Hess, Georg, et al.
Publicado: (2020)

TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
por: Schmitz, Roland, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_jfkhjtm5m5un5nqsklup6tiph6